| Ytd | -51.24% | |
| 1y | -69.27% |
| Open | 0.23 | Prev Close | 0.22 | Low | 0.23 | High | 0.26 | Mkt Cap | 24.43M |
| Vol | 5.44M | Avg Vol | 9.86M | EPS | -0.72 | P/E | N/A | Forward P/E | -12.36 |
| Beta | 3.14 | Short Ratio | 2.56 | Inst. Own | 10.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-16 | 50-d Avg | 0.22 | 200-d Avg | 0.36 | 1yr Est | 3.00 |
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regul
$8 million senior secured ATW convertible note satisfied, together with all accrued interest, twelve
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the
Initial purchase order of 126,000 Sky Premium Life units secured on execution of the agreementExclus
Cosmos Health Enters Saudi Arabia. Signs Exclusive Distribution Agreement With Innova Healthcare; Se
Cosmos Health (NASDAQ:COSM) reported quarterly losses of $(0.10) per share which missed the analyst
Highest Q2 and H1 revenue in Company history, reflecting strength across all core segments and reach
Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market s
KEYS stock rose 3% in pre-market trading due to strong financial results and guidance. Other gainers
Digital subscription platform brings together the Company's proprietary consumer health products acr
Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average mon
Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average mon
Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-mar
CHICAGO, July 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NA
CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (N
CHICAGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NA
CHICAGO, July 14, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NA
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
CHICAGO, July 13, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NA
Cosmos Health will supply DIABIT-IS X (sitagliptin), while Libytec handles distribution and promotio
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Subscription model already launched with NOOR Collagen in the United States Early data shows a repea
CHICAGO, July 09, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NA
CHICAGO, July 08, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NA
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
CHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NA
Record Q2 2026 revenue of approximately $19.4 million, up approximately 31.5% year-over-year from $1
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Building on Its Recent Acquisition of the CCX0722 Intellectual Property, Cosmos Health Owns the Tech
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Tower Semiconductor (TSEM) jumped 4.7% in pre-market trading after announcing a multi-year supply ag
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Strong sales momentum: across the UK and Greece, the brands' first two markets.Over $1.5 million
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Under the new five-year agreement, Cana will manufacture 385,000 units of CERTORUN® (sertraline hydr
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,
Significant Deleveraging: Total liabilities decreased by $4.5 million, or 9.6%, quarter-over-quarter
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,